Introduction
The patched gene encodes the transmembrane protein Patched (Ptc), which acts as a receptor for Sonic hedgehog (Shh), a secreted molecule essential for formation of a wide variety of organs during embryonic development. In the absence of Shh, Ptc forms an inactive complex with Smoothened (Smo), another transmembrane protein. When Shh binds to Ptc, the complex changes conformation, and Smo become activated to transduce the signal to the nucleus (Marigo et al., 1996a; Stone et al., 1996; Ingham, 1998; Goodrich and Scott, 1998; Johnson and Scott, 1998; Hahn et al., 1999; Villavicencio et al., 2000) . With respect to the target genes of the Shh/Ptc/Smo signaling pathway, the gli1 gene has been well studied Ruiz i Altaba, 1998) . This gene encodes a transcription factor with zinc ®nger motifs and has been reported to be induced by endogenous and ectopic Shh in developing limb buds and neural tubes (Kinzler et al., 1987; Ruppert et al., 1991; Dahmane et al., 1997) . Gli1 induction is most likely mediated by Gli3 protein, another transcription factor belonging to the Gli family, through the Gli binding site in the promoter of the gli1 gene (Liu et al., 1998 , Akimaru et al., 1997 , Dai et al., 1999 , Sasaki et al., 1999 Wang et al., 2000) .
Germline mutations in the human homologue of patched cause Gorlin syndrome, an autosomal dominant disorder characterized by multiple basal cell carcinomas, other tumors including medulloblastomas and congenital abnormalities of the brain, bones and teeth (Gailani et al., 1992; Johnson et al., 1996; Lavanat et al., 1996; Lench et al., 1997; Smyth et al., 1998) . Somatic mutations in the patched gene have been identi®ed in sporadic basal cell carcinomas at a frequency of 20 ± 30% (Gailani et al., 1996; Fan et al., 1997; Unden et al., 1997; Wolter et al., 1997; Xie et al., 1997) . Somatic mutations in patched have also been identi®ed in medulloblastomas (Pietsch et al., 1997; Rael et al., 1997; Zurawel et al., 2000a) , squamous cell carcinomas (SCCs) (Ahmadian et al., 1998; Ping et al., 2001) , trichoepitheriomas (Vorechovsky et al., 1997) , meningiomas, breast carcinomas (Xie et al., 1997) and esophageal carcinomas (Maesawa et al., 1998) . Whereas loss of heterozygosity (LOH) of the patched gene was detected in some of these sporadic tumors, some tumor cells retained the wild-type patched allele. Heterozygous patched knockout mice display some of the symptoms typical of Gorlin syndrome (Goodrich et al., 1997; Hahn et al., 1998) . Tumors such as medulloblastomas observed in humans were also found in the knockout mice (Hahn et al., 1999) . Ultraviolet and ionizing radiation have been shown to enhance the growth of basal cell carcinomas and tricoblastomas in patched heterozygous knockout mice (Aszterbaum et al., 1999) . The observation that the wild-type patched allele was retained and expressed in medulloblastomas in heterozygous patched knockout mice indicates that patched is not acting as a classic tumor suppressor gene in this system (Goodrich et al., 1997; Wetmore et al., 2000; Zurawel et al., 2000b) .
It was shown recently that several established cell lines derived from human SCCs possessed patched mutations (Michimukai et al., 2001) . Such cell lines include A431, which was derived from vulva and was shown to have a point mutation in both alleles of the patched gene. Although the A431 cell line has been studied extensively and reported to express epidermal growth factor (EGF) receptors at high levels and a mutated form of p53 (Merlino et al., 1984; Ullrich et al., 1984; Kwok et al., 1994) , the critical factors for development of this tumor are not fully understood.
In the present study, we introduced the wild-type patched gene into several cell lines derived from SCC with or without mutations in the patched gene to determine whether the patched mutations found in sporadic tumors are responsible for acquisition of oncogenic potential. If the mutant forms of Ptc in the SSC cell lines cause constitutive activation of Shh/Ptc/ Smo signaling pathway, high level expression of exogenous wild-type Ptc is expected to bind to the endogenous Smo, leading to the suppression of the pathway. We used VSV-G pseudotyped retrovirus vectors, which can introduce exogenous genes into the entire population of most human tumor cell lines by a single transduction (Arai et al., 1998 Ui et al., , 2000 . We demonstrate here that the anchorage independent growth of several human SCC cell lines with patched mutations was suppressed eciently by Ptc virus suggesting the potential therapeutic importance of this viral vector.
Results

Experimental strategy
In the present study, we concentrated on analysis of three human SCC cell lines, A431, KA and NA. KA and NA were derived from oral SSC of dierent patients. Analysis of the genomic sequence of the patched gene in A431 cells revealed a single point mutation in exon 23 of both alleles of patched, resulting in a proline to leucine at 1315, whereas NA showed no patched mutation (Michimukai et al., 2001 ).
Analysis of the genomic sequence of the patched gene in KA cells revealed a point mutant in exon 12, which causes a T to G transversion at nucleotide 1682 and results in a methionine to arginine change at amino acid, 561 in one allele of patched (Michimukai et al., 2001) .
To obtain further insight into the patched gene in KA cells, the entire patched mRNA in KA cells was analysed by RT ± PCR. When mRNA was ampli®ed by PCR with a primer pair exon 12 and sequenced directly, only the mutant patched mRNA was detected (Figure 1) . The other patched allele in KA cells might have mutations outside the genomic region which we examined and that aected its transcription, it is also possible that the wild-type allele is epigenitically silenced. Therefore, we used A431 and KA as cells that express exclusively mutant patched and NA cells were used as a control SSC cell line with the wild-type patched gene. NIH3T3 cells transformed with activated human K-ras gene (Ras-NIH3T3) were used as a control for cells transformed with a single oncogene.
To introduce the wild-type patched gene into these cell lines, we used a VSV-G pseudotyped retrovirus vector, because it can introduce genes into the entire population of most cell lines derived from human solid tumors by a single transduction. Furthermore, the average copy number of proviral DNA can be easily regulated by simply changing the viral dosage (Arai et al., 1998; Ui et al., 2000) . For example, gene transfer at an average dosage of 1 copy or 3 copies of provirus per cell can be achieved by transducting the cell line with Figure 1 Mutation in exon 12 of the patched gene as detected in mRNA isolated from KA cells. The exon 12 RT ± PCR product was sequenced directly. The sense sequence (nucleotides 1675 to 1692) is shown, and a point mutation at nucleotide 1682 (T to G transversion) that causes methionine to arginine change is indicated by the arrow retrovirus vector at an MOI of 0.1 or 3, respectively, and following this with puromycin selection for 4 ± 5 days. Here we de®ned the MOI as the ratio of the input infectious virus particles (titrated on a corresponding cell line as an indicator) to the number of cells in the culture used for the transduction. A431 cells, which had been transduced with Ptc virus at MOIs of 0.1 and 3 and subsequently selected with puromycin, were shown to harbor approximately, 0.9 and 3.6 copies respectively, of proviral DNA per cell when analysed by Southern blot analysis (data not shown).
Exogenous expression of patched suppresses anchorage independent growth of SCC cell lines
We ®rst analysed the eect of introduction of the wildtype patched gene on the growth properties of cells grown as monolayer cultures. Growth curve analysis was used to compare the growth rates and saturation densities of A431, KA, NA and Ras-NIH3T3 cells transduced with Ptc virus with those of corresponding cells transduced with control virus at the same dosage. In all the cell lines examined, no signi®cant inhibition of growth was observed after introduction of patched, as judged from both growth rates and saturation densities (Table 1) .
To con®rm that Ptc virus-transduction induces high level expression of exogenous Ptc (chicken) protein in these cell lines, Western blot analysis was performed using polyclonal antibody raised against the peptide (composed of 19 amino acids) in the C-terminal region of human Ptc, which has two amino acid substitutions from the corresponding region of chicken Ptc. When cell lysates were prepared from A431 and KA cells that were transduced with Ptc virus at MOI of 3, Ptc protein was detected as a broad band which ranged from 160 to 190 KDa ( Figure 2 ) as was reported for human Ptc (Stone et al., 1996; Karpen et al., 2001) . When these cells were transduced with control virus, however, only a very faint band of endogenous Ptc was detected instead. These results indicate that Ptc virus induces signi®cant amount of exogenous Ptc that would be sucient to compete for the mutant forms of endogenous Ptc protein.
We next analysed the eects of patched gene introduction on anchorage independent growth. The numbers of colonies formed in soft agar were counted after seeding of the same number of cells transduced with either Ptc virus or control virus. In A431 cells, colony formation was reduced to 35 and 21% control values by transduction of or 3 copies of patched, respectively. Although a similar dose-dependent reduction was obtained in KA cells, the eect was marginal when NA cells were used. The colony forming activity of Ras-NIH3T3 was not aected by patched transduction (Table 1, Figure 3 ). These results indicate that introduction of exogenous wild-type patched can eciently suppress anchorage independent growth in cells that express mutant patched mRNA. Because expression of exogenous patched had no eect on growth of monolayer cultures, the suppression of anchorage independent growth does not appear to be due to non-speci®c growth inhibition.
Ptc virus-transduced A431 and KA cells recover anchorage independent growth in the presence of Shh High level expression of exogenous wild-type Ptc would suppress Smo function of generating intracellular signals by replacing a mutant Ptc that lacks Smosuppressing activity. If this is the case, we would expect extracellular Shh to cancel out the suppressive eect of exogenously introduced Ptc. To test this possibility, Shh was synthesized in E. coli, puri®ed and added to the soft agar cultures. Whereas control virus-transduced A431 and KA cells formed colonies at similar eciencies independent of the addition of Shh, the reduction in colony formation in Ptc virus-transduced A431 or KA cells was inhibited by Shh treatment 
Cyclopamine suppresses colony formation by SCC cell lines
Cyclopamine is a steroidal alkaloid produced by Veratrum californicum that causes sheep cyclopia by blocking the Shh/Ptc/Smo signaling pathway (Cooper et al., 1998; Bale, 2000; Incardona et al., 2000) . To analyse the eect of cyclopamine on anchorage independent growth, colony formation assays were performed in soft agar with several concentrations of cyclopamine. In Ras-NIH3T3 cells, no signi®cant inhibition of colony formation in soft agar was observed, even at 5 mM. Colony forming activities of A431 and KA cells were inhibited signi®cantly by cyclopamine in a dose-dependent manner, indicating that in SCC cell lines expressing mutant patched, cyclopamine eciently suppresses anchorage independent growth. In NA cells, we observed some inhibitory eects on colony forming activity (Figure 4 ) but to a lesser extent than that observed in A431 and KA cells. This inhibition might be caused in part by a cytostatic eect of cyclopamine (5 mM) observed in this cell line in monolayer cultures. Therefore, in SCC cell lines with mutant patched, cyclopamine treatment has eects c Shh was added to both top and bottom agars at a concentration of 200 ng/ml similar to those of exogenous expression of patched, indicating that these molecules inhibit the same pathway, the Shh/Ptc/Smo signaling pathway.
Exogenous expression of patched reduces expression of the gli1 gene
We then analysed expression of gli1, one of the target genes of the Shh/Ptc/Smo signaling pathway, before and after introduction of the wild-type patched gene into SCC cell lines. Expression of endogenous gli1 was much higher in A431 and KA cells than in NA cells. This observation is consistent with the idea that the Shh/Ptc/Smo pathway is constitutively activated in cell lines de®cient in expression of wild-type patched. The high level expression of gli1 in A431 and in KA was reduced almost 50%, when exogenous wild-type patched was introduced. In NA cells, which express wild-type patched, gli1 expression was also reduced by exogenous patched although to a lesser extent ( Figure  5a,b) . These results indicate that the signaling pathway from Smo to the nuclear target is functional in these three SCC cell lines independent of the presence of a functional endogenous patched gene.
Expression of patched is induced by Shh in developing neural tubes or limb buds, and therefore the endogenous patched gene could be a target of the Shh/Ptc/Smo pathway Marigo et al., 1996a) . When PCR primers speci®c for the 3'-noncoding region of human patched gene were used to assess the endogenous gene expression, similar levels of patched expression was detected in all three cell lines. Expression of exogenous patched reduced the level of expression of endogenous patched dramatically in A431 cells and slightly in KA cells; no change was observed in NA cells (Figure 5a,b) . These results suggest that the endogenous patched gene may not be a direct target of the Shh/Ptc/Smo pathway but that it is strongly autoregulated in some cell lines, including A431. 3 cells) were seeded into soft agar in 60-mm dishes in the absence or presence (®nal concentrations 1 mM, 2 mM, 5 mM and 10 mM, respectively) of cyclopamine, and incubated at 378C for 23 ± 31 days before colony counting. The percentage of colonies that formed in the absence of cyclopamine is shown a b Figure 5 Semiquantitative RT ± PCR analysis of RNAs isolated from SCC cells that are transduced with control virus or Ptc virus. Total RNAs were extracted from the three SCC cell lines that were transduced with control virus (7) or Ptc virus (+) cells, at the MOI of 3. Ampli®ed RT ± PCR products for GAPDH, gli1 and endogenous patched were visualized with SYBR Green I after 5% polyacrylamide gel electrophoresis (a). The gel shown in (a) as well as a similar gel of RT ± PCR products that were prepared independently was semi-quanti®ed by densitometry (ATTO Printgraph). The average ratios of expression levels of each gene in Ptc virus-transduced cells relative to those in control virustransduced cells were calculated and shown (b). GAPDH (white boxes), gli1 (black boxes) and endogenous patched (slashed boxes) were shown Suppression of tumorigenicity of A431 by patched C Koike et al SupJunD-1 suppresses anchorage independent growth of SCC cells with wild-type patched but not of those with mutant patched
We previously reported that the anchorage independent growth of most of human solid tumor cell lines examined (U2-OS, Saos-2, A549, H1299, Hela and SiHa cells) are suppressed by the transduction of VSV-G pseudotyped retrovirus vectors expressing SupJunD-1, a dominant negative form of transcription factor AP-1 (Ui et al., 2000) . SupJunD-1, however, had no or marginal eects on the growth properties in monolayer cultures of these cells as monitored by growth rate and saturation density. We have examined the biological eects of SupJunD-1 on SCC cell lines to compare the target cell speci®city between these two anti-oncogenes. A431, KA and NA cell lines were transduced with SupJunD-1 virus, and the growth properties both in monolayer cultures and in soft agar were examined. No signi®cant inhibition of growth was observed in monolayer cultures of the cell lines examined (Table  3 ). In Ras-NIH3T3 cells, the colony forming activity was reduced by introduction of SupJunD-1 virus at 1 copy (41%) or 3 copies (19%), as reported previously (Ui et al., 2000) . In NA cells, the colony formation was also reduced to 42 and 18% in cells harboring 1 or 3 copies of the supjunD-1 gene, respectively. The numbers of colonies formed by A431 and KA cells were not reduced signi®cantly by introduction of the supjunD-1 gene, although the average colony size of A431 cells was slightly reduced when SupJunD-1 virus was introduced (Table 3 ). These ®ndings indicated that in SCC cells with point mutations on the patched gene, oncogenic potential is not suppressed signi®cantly by the inhibition of the AP-1 pathway revealing mutually exclusive target cell speci®city of these two antioncogenes, patched and supjunD-1.
Discussion
The SCC cell lines A431 and KA express exclusively mutant forms of the patched gene; A431 has a proline to leucine substitution at amino acid 1315, and KA has a methionine to arginine at amino acid 561. Although these point mutations have not been reported in basal cell carcinomas or medulloblastomas, they were found in the present study to play essential roles in the formation of the squamous cell carcinomas. Introduction of wild-type patched eciently suppressed the anchorage independent growth of these two cell lines without aecting their growth properties in monolayer cultures. Addition of recombinant Shh protein to the soft agar cultures of A431 and KA cells expressing exogenously introduced patched restored their abilities to grow in soft agar, indicating that all other molecules involved in the Shh/Ptc/Smo signaling pathway are functional even in these cell lines. In consistent with these observations, endogenous gli1 expression is much higher in A431 and KA than in NA possibly by the constitutive activation of the pathway by the unsuppressed Smo protein. Furthermore, gli1 expression was reduced in response to exogenous expression of patched in all three cell lines. We also demonstrated that cyclopamine, a speci®c inhibitor of the Shh/Ptc/Smo signaling pathway, suppresses colony formation by A431 and KA cells in soft agar (Table 3 ). The exact mechanism by which cyclopamine acts is not fully understood, it has been reported that cyclopamine or synthetic derivatives with improved potency, such as KAAD-cyclopamine, block activation of the Shh/Ptc/Smo signaling pathway in primary ®broblasts derived from ptc 7/7 mice or NIH-3T3 cells that express a constitutively active form of Smo (Taipale et al., 2000) . KAAD-cyclopamine may be eective to suppressing the colony formation of human cell lines with less cytopathic eects than cyclopamine.
We recently reported that in several tumor cell lines derived from human osteosarcomas, non-small cell lung carcinomas and cervical carcinomas, the oncogenic potential was eciently suppressed by SupJunD-1, a dominant negative mutant of AP-1 (Ui et al., 2000) . SupjunD-1 and similar dominant negative forms of AP-1, such as SupJun-1 (Suzuki et al., 1994) or SupFos-1 (Okuno et al., 1991) , have been shown to revert the transforming activity induced by oncogenes such as src, yes, fps, ras and raf as well as fos and jun family members and by a constitutively active form of MEK (Murakami et al., 1999) , indicating that these engineered anti-oncogenes can eectively to suppress endogenous MAP kinase activities. Interestingly, SupJun-1 was also reported to inhibit cellular transformation induced by NFkB family genes (Kralova et al., 1998) . Therefore, both A431 and KA cells are exceptional cell lines in that their oncogenic potentials are not reduced appreciably by SupJunD-1. In contrast, the oncogenic potentials of the SCC cell line 
Materials and methods
Cell lines
The prepackaging cell line for VSV-G pseudotyped vector production, PtG-S2 (Arai et al., 1998) , and rat ®broblast cell line 3Y1 were maintained in Dulbecco's Modi®ed Eagle's Medium (DMEM) (high glucose, Gibco/BRL) supplemented with 10% fetal calf serum. PtG-S2 and its derivatives were grown in the presence of 4 mg/ml blasticidin S (Funakoshi) and 1 mg/ml G418 (Gibco BRL). Ras-NIH3T3 (Okazaki et al., 1998) cells were maintained in DMEM (low glucose, Gibco BRL) supplemented with 10% calf serum in the presence of 400 mg/ml G418. Human squamous cell carcinoma cell line A431 was maintained in DMEM nutrient mixture F-12 HAM (DMEM/F-12) (Sigma; St. Louis, MO, USA) supplemented with 5% calf serum. Human squamous cell carcinoma cell lines KA and NA were maintained in a mixture of RPMI-1640 and DMEM supplemented with 5% calf serum. Concentrations of puromycin used to select PtG ± S2, NIH3T3 and three squamous cell carcinoma cell lines (A431, KA and NA) were 1, 2 and 0.8 mg/ml, respectively. All the cells were kept at 37.08C. Cyclopamine (Incardona et al., 1998 ) (a kind gift from Dr W Gaeld) was stocked as a 10 mM solution in 95% ethanol. Recombinant Shh-N was synthesized and puri®ed from E. coli as described (Michimukai et al., 2001) .
Plasmid construction and preparation of retrovirus vectors
The 4.8-kb BamHI fragment carrying the entire coding sequence of the chicken patched cDNA was excised from pBS-PTC (Marigo et al., 1996b ) (a kind gift from Dr CJ Tabin) and inserted into the unique BglII site of pBabeIRESpuro (Ui et al., 2000) to generate pBabe-cptc-IRESpuro. pBabe-cptc-IRESpuro (4 mg) was transfected into PtG-S2 (2610 6 cells/100-mm dish) with Lipofectamine Plus Reagent (Gibco BRL). The clones of transfectants were selected with puromycin and isolated. The clone that produced the highest titer of VSV-S pseudotyped vector was selected for further study. Control virus or SupJunD-1 virus were prepared with pBabe-IRESpuro and pBabe-supjunD-1-IRESpuro, respectively, as described previously (Ui et al., 2000) .For titration of retrovirus, cells were transduced with a series of diluted virus stocks and clones expressing vector RNA were evaluated by in situ hybridization with digoxigeni-labeled antisense RNA of gag as described previously (Ui et al., 2000) .
Colony formation in soft agar
Cells were seeded at 3610 4 cells (A431), 3610 4 cells (KA) or 3610 3 cells (Ras-NIH3T3) into 60-mm dishes in a suspension of 0.38% Noble agar (Difco) in DMEM (low glucose) supplemented with 10% fetal calf serum on top of a bed of 0.5% Bacto agar (Difco) in the same complete medium. For NA and its derivatives, cells were seeded at 1610 5 cells into 60-mm dishes in a suspension of 0.3% Noble agar in DMEM/F-12 supplemented with 10% calf serum, 10 mg/ml insulin (Sigma), 5 mg/ml transferrin (Sigma), 10 mM 2-mercaptoethanol (Sigma), 10 mM 2-aminoethanol (Sigma) and 10 nM sodium selenite (Sigma) on top of a bed of 0.5% Bacto agar in the same complete medium. Colonies that had formed after 15 to 30 days incubation were counted.
Growth curve
Cells were seeded at 1.5610 3 cells/300 ml well in 48-well plates, maintained at 378C. Media was changed at 3 day intervals. Everyday, three culture aliquots were mited with 5 mg/ml MTT (Sigma), incubated at 378C for 4 h, disrupted and suspended in 1 ml of dimethylsulfoxide (Dojindo). OD 540 of the mixtures were measured, and the averages of the three readings were plotted for the growth curve. Growth rates were determined with the logarithmic phase of the growth curve.
Western blot analysis
Cell lysates were prepared under denaturing conditions. The protein samples (30 mg protein/lane) were separated by 6% SDS-polyacrylamide gel electrophoresis. The Ptc proteins were detected by Western blotting using rabbit polyclonal antibody raised against the peptide (RLPTPSPEPPPSVVR-FAMP) in the C terminal region of Ptc (human) (a kind gift from Dr AE Bale) (Karpen et al., 2001) . Bands were visualized by use of the ECL Western blotting detection system (Amersham). The molecular weight of Ptc protein was estimated using prestained standard markers (broad range, BIO-RAD) migrated in the adjacent lanes.
RT ± PCR and direct sequencing
Total cellular RNA (1 mg) from KA cells was reverse transcribed with MuLV reverse transcriptase and random hexamers. Ampli®cation of exon 12 of the patched gene was accomplished with primers F5'-GCCTTCAGTGAAACAG-GACAG-3' and R5'-GAACACCACTACTACCGCTGC-3', generating a 189-bp fragment. The reaction pro®le consisted of a initial denaturation at 958C for 10 min, followed by 35 cycles of 958C for 30 s, 558C for 1 min and 728C for 1 min, and a ®nal extension at 728C for 10 min. The entire reaction was puri®ed with a QIAquick PCR Puri®cation Kit (Qiagen), and the product was visualized by 2% agarose gel electrophoresis.
The puri®ed product was sequenced in both directions by direct sequence analysis with an Applied Biosystems 310 Sequencer (Perkin-Elmer Cetus). Twenty-®ve cycles of thermal sequence reaction was carried out with the dRhodamine Terminator Cycle Sequencing Ready Reaction Kit (Perkin-Elmer) according to the manufacturer's instructions. Each reaction contained 200 ng of puri®ed PCR product, 1 ml of sense or antisense primer (25 pM), and 4 ml of dRhodamine Terminator RR Mix. Cycling conditions consisted of a hot start at 968C, followed by 10 s at 968C, 15 s at 508C and 4 min at 608C for each cycle. The product was precipitated with ethanol and air-dried. The pellet was dissolved in 13 ml of template suspension reagent, denatured at 958C for 3 min, and plunged into ice prior to loading for sequencing.
Semi-quantitative RT ± PCR analysis
Total RNAs were isolated from each cell with Isogen (Nippon-Gene) and treated with DNase. The patched, gli1, gli2, gli3 and GAPDH transcripts were ampli®ed by RT ± PCR with the Superscript One-Step RT ± PCR Taq Kit (LifeTechnologies). The following primers were used to amplify the human patched cDNA: F5'-GAGGCCAAAGATTG-GAAACC-3' and R5'-ACAAATTGGGGTCCTGGATG-3'. The reaction pro®le consisted of an initial denaturation at 948C for 2 min followed by 28 cycles of 948C for 30 s, 628C for 1 min and 728C for 1 min with a ®nal extension at 728C for 5 min. Primers and PCR conditions for gli1, gli2, gli3 (Palm et al., 2000) and GAPDH (Ito et al., 2001) were described previously. Cycles for the PCR reaction were 28 (patched), 32 (gli1), 28 (gli2), 24 (gli3), and 26 (GAPDH), respectively.
